About Nirvana Sciences
Nirvana Sciences is a company based in Durham (United States) founded in 2013. Nirvana Sciences has raised $3.5 million across 7 funding rounds from investors including HHS and ThreeD Capital. Nirvana Sciences offers products and services including Synthetic Bacteriochlorins, Synthetic Chlorins, and Polystyrene Beads. Nirvana Sciences operates in a competitive market with competitors including NuProbe, Nanosphere, 3Helix, ATDBio and OliLux, among others.
- Headquarter Durham, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Nirvana Sciences, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$3.5 M (USD)
in 7 rounds
-
Latest Funding Round
$867 K (USD), Series A
May 26, 2021
-
Investors
HHS
& 1 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Nirvana Sciences
Nirvana Sciences offers a comprehensive portfolio of products and services, including Synthetic Bacteriochlorins, Synthetic Chlorins, and Polystyrene Beads.
Dyes with narrow emissions for life science multiplexing applications
Dyes offering enhanced properties for biomedical research needs
Beads with red and near-infrared emissions for scientific uses
People of Nirvana Sciences
Unlock access to complete
Unlock access to complete
Advisor Team
4 people
Member Team
2 people
Finance and Accounting
2 people
Leadership Team
1 people
Chairman Team
1 people
Unlock access to complete
Funding Insights of Nirvana Sciences
Nirvana Sciences has successfully raised a total of $3.5M across 7 strategic funding rounds. The most recent funding activity was a Series A round of $867 thousand completed in May 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Nirvana Sciences
Nirvana Sciences has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include HHS and ThreeD Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital firm focused on multiple sectors
|
Locked | Locked | Locked | |
|
Public health and human services are overseen by HHS.
|
Locked | Locked | Locked |
Investor details for Nirvana Sciences
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Nirvana Sciences
Investment portfolio details for Nirvana Sciences
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Nirvana Sciences
Detailed financials for Nirvana Sciences
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Nirvana Sciences Comparisons
Peer comparison for Nirvana Sciences
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Nirvana Sciences
Nirvana Sciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as NuProbe, Nanosphere, 3Helix, ATDBio and OliLux, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Sensitive multiplex platforms for QPCR are developed using toehold probes.
|
|
| Locked | Locked | Locked |
Diagnostic tests for personalized medicine targeting infections are provided.
|
|
| Locked | Locked | Locked |
Reagents for binding denatured collagen are developed and offered.
|
|
| Locked | Locked | Locked |
Developer of oligonucleotides
|
|
| Locked | Locked | Locked |
Tuberculosis detection dyes are provided by OliLux.
|
Detailed competitors of Nirvana Sciences
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Nirvana Sciences
Complete news archive for Nirvana Sciences
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Nirvana Sciences
Nirvana Sciences was founded in 2013 and raised its 1st funding round 1 year after it was founded.
Nirvana Sciences is headquartered in Durham, United States. It is registered at Durham, North Carolina, United States.
Nirvana Sciences is a funded company, having raised a total of $3.5M across 7 funding rounds to date.
Nirvana Sciences was established in 2013 in Durham, United States, within the medical diagnostics sector. Fluorescent dyes are produced and supplied for imaging systems and tests. These dyes feature ultra-narrow emissions to simplify detection processes and support multiplexing in research applications. Utilization occurs in areas such as flow cytometry, imaging cytometry, photoacoustic imaging, and various molecular diagnostics.
Nirvana Sciences's top competitors include NuProbe, Nanosphere and ATDBio.
Nirvana Sciences offers Synthetic Bacteriochlorins, Synthetic Chlorins, and Polystyrene Beads.
Nirvana Sciences has 2 investors. Key investors include HHS, and ThreeD Capital.